Quick Takeaways
- Steven Gillis has 4 issuer positions tracked on this page.
- Estimated disclosed ownership value: $2,034,735.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Steven Gillis
- Location
- Chicago, IL
- Summary
- The estimated net worth of Steven Gillis is at least $2,034,735 dollars as of 18 Mar 2026. Steven Gillis is the Director of VBI Vaccines Inc/BC and owns shares of VBI Vaccines Inc/BC stock worth about $1.73M. Steven Gillis is the Director of Homology Medicines, Inc. and owns shares of Q32 Bio Inc. (QTTB) stock worth about $308.7K.
- Signature
- /s/ Max Heuer, by power of attorney, for Steven Gillis
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Steven Gillis and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: VBI Vaccines Inc/BC ($1,726,075).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Steven Gillis
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| VBIV | VBI Vaccines Inc/BC | Director | $1,726,075 | 27 Jul 2023 | ||
| QTTB | Homology Medicines, Inc. | Director | $308,660 | 14 Jun 2023 | ||
| CDAKQ | Codiak BioSciences, Inc. | Director | 16 Feb 2023 | |||
| TAK, TKPHF | TAKEDA PHARMACEUTICAL CO LTD | Director | 18 Mar 2026 |
Insider Transactions Reported by Steven Gillis:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.